Back
Beam Therapeutics Stock Price Chart
Sponsored
BEAM
Sponsored
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
49
BEAM
Beam Therapeutics
Last Price:
$29.04
Seasonality Move:
0.32%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BEAM is experiencing buying pressure, which is a positive indicator for future bullish movement.
Beam Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.09 | Buy |
20-day SMA: | 27.34 | Buy |
50-day SMA: | 25.66 | Buy |
200-day SMA: | 26.04 | Buy |
8-day EMA: | 27.91 | Buy |
20-day EMA: | 27.33 | Buy |
50-day EMA: | 26.28 | Buy |
200-day EMA: | 26.29 | Buy |
Beam Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.7 | Buy |
Relative Strength Index (14 RSI): | 57.02 | Buy |
Chaikin Money Flow: | 2387500 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.01 - 28.47) | Buy |
Bollinger Bands (100): | (23.32 - 27.4) | Buy |
Beam Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Beam Therapeutics Stock
Is Beam Therapeutics Stock a Buy?
-
Beam Therapeutics share price is 29.04 while BEAM 8-day simple moving average is 28.09, which is a Buy signal.
-
The stock price of BEAM is 29.04 while Beam Therapeutics 20-day SMA is 27.34, which makes it a Buy.
-
Beam Therapeutics 50-day simple moving average is 25.66 while BEAM share price is 29.04, making it a Buy technically.
-
BEAM stock price is 29.04 and Beam Therapeutics 200-day simple moving average is 26.04, creating a Buy signal.
BEAM Technical Analysis vs Fundamental Analysis
Sell
49
Beam Therapeutics (BEAM)
is a Sell
Is Beam Therapeutics a Buy or a Sell?
-
Beam Therapeutics stock is rated a SellThe current Beam Therapeutics [BEAM] share price is $29.04. The Score for BEAM is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Beam Therapeutics Stock Info
Market Cap:
2.4B
Price in USD:
29.04
Share Volume:
2.7M
Beam Therapeutics 52-Week Range
52-Week High:
49.50
52-Week Low:
20.84
Sell
49
Beam Therapeutics (BEAM)
is a Sell
Beam Therapeutics Share Price Forecast
-
What is the Beam Therapeutics stock price today?The Beam Therapeutics stock price is 29.04 USD today.
-
Will BEAM stock go up or go down?Beam Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Beam Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Beam Therapeutics is overvalued.
Is Beam Therapeutics Stock a Buy?
-
Beam Therapeutics share price is 29.04 while BEAM 8-day exponential moving average is 27.91, which is a Buy signal.
-
The stock price of BEAM is 29.04 while Beam Therapeutics 20-day EMA is 27.33, which makes it a Buy.
-
Beam Therapeutics 50-day exponential moving average is 26.28 while BEAM share price is 29.04, making it a Buy technically.
-
BEAM stock price is 29.04 and Beam Therapeutics 200-day simple moving average is 26.29, creating a Buy signal.
Fundamental Analysis of Beam Therapeutics
Is Beam Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.58 per share, and a decrease next year of $0.07 per share.
Technical Analysis of Beam Therapeutics
Should I short Beam Therapeutics stock?
-
BEAM Moving Average Covergence Divergence (MACD) indicator is 0.7, suggesting Beam Therapeutics is a Buy
-
Beam Therapeutics Relative Strength Index (RSI) is 57.02, which suggest Beam Therapeutics is overbought
-
The Bollinger Bands (25) for Beam Therapeutics is (25.01 - 28.47), which suggest Beam Therapeutics is a Buy
-
The Bollinger Bands (100) for Beam Therapeutics is (23.32 - 27.4), which suggest Beam Therapeutics is a Buy
* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.